Loading clinical trials...
Loading clinical trials...
Myeloid-derived Suppressor Cells (MDSCs) Detection Before and After Beta-glucan Administration in Oral Squamous Cell Carcinoma Patients
Conditions
Interventions
β-glucan
Locations
1
Taiwan
National Taiwan University Hospital
Taipei, Taiwan
Start Date
March 22, 2017
Primary Completion Date
December 31, 2019
Completion Date
March 21, 2021
Last Updated
May 14, 2020
NCT06030440
NCT07203911
NCT04191460
NCT03370276
NCT06086925
NCT05608369
Lead Sponsor
National Taiwan University Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions